74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Corbion NV
Closed
SectorFinance
17.5 -0.11
Overview
Share price change
24h
Min
17.5
Max
17.52
Recommendations | Buy |
|---|---|
12 Months Forecast | +32.25% upside |
News Sentiment
By Acuity
100%
0%
500 / 528 Finance
Corbion NV Chart
Past performance is not a reliable indicator of future results.
Related News
Corbion NV Forecast
Price Target
By TipRanks
32.25% upside
12 Months Forecast
Average 23.17 EUR 32.25%
High 31 EUR
Low 16.5 EUR
Based on 3 Wall Street analysts offering 12 month price targets forCorbion NV - Dist in the last 3 months.
Sentiment
By Acuity
500 / 528 Finance
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Corbion NV
Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was incorporated in 1919 and is headquartered in Amsterdam, the Netherlands.
Live chat